Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Vulvar Neoplasms × Drug Therapy × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 21 Colorectal Neoplasms 10 Neoplasms 9 Stomach Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Lung Neoplasms 7 Neoplasm Metastasis 5 Colonic Neoplasms 5 Esophageal Squamous Cell Carcinoma 4 Esophageal Neoplasms 4 Triple Negative Breast Neoplasms 3 Small Cell Lung Carcinoma 3 Pancreatic Neoplasms 3 Lymphoma, Follicular 3 Leukemia, Myeloid, Acute 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Osteosarcoma 2 Neoplasms, Second Primary 2 Multiple Myeloma 2 Melanoma 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Head and Neck Neoplasms 2 Fatigue 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Thyroid Diseases 1

Interventions

Surveys and Questionnaires 3 Surgical Procedures, Operative 2 trastuzumab deruxtecan 1 Watchful Waiting 1 Sentinel Lymph Node Biopsy 1 Radiotherapy 1 RNA 1 Psychiatric Rehabilitation 1 Observation 1 Multimodal Imaging 1 Indocyanine Green 1 Immunohistochemistry 1 Hysterectomy 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Drug Therapy 1 DNA 1 Circulating Tumor DNA 1 CA-125 Antigen 1 Buthionine Sulfoximine 1 Brachytherapy 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02067052 2022-04-15

New Strategy for the Treatment of Vulvar Cancer

Instituto do Cancer do Estado de São Paulo

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡